DE602004031435D1 - Cycloalkyl-heterozyklen zur behandlung des hepatitis-c-virus - Google Patents
Cycloalkyl-heterozyklen zur behandlung des hepatitis-c-virusInfo
- Publication number
- DE602004031435D1 DE602004031435D1 DE602004031435T DE602004031435T DE602004031435D1 DE 602004031435 D1 DE602004031435 D1 DE 602004031435D1 DE 602004031435 T DE602004031435 T DE 602004031435T DE 602004031435 T DE602004031435 T DE 602004031435T DE 602004031435 D1 DE602004031435 D1 DE 602004031435D1
- Authority
- DE
- Germany
- Prior art keywords
- hepatitis
- virus
- treatment
- heterocycles
- cycloalkyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 241000711549 Hepacivirus C Species 0.000 title 1
- 208000005176 Hepatitis C Diseases 0.000 abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 2
- 108060004795 Methyltransferase Proteins 0.000 abstract 1
- 101800001554 RNA-directed RNA polymerase Proteins 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Virology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Oncology (AREA)
- Molecular Biology (AREA)
- Communicable Diseases (AREA)
- Gastroenterology & Hepatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US50206703P | 2003-09-11 | 2003-09-11 | |
| PCT/US2004/027533 WO2005034850A2 (en) | 2003-09-11 | 2004-08-24 | Cycloalkyl heterocycles for treating hepatitis c virus |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DE602004031435D1 true DE602004031435D1 (de) | 2011-03-31 |
Family
ID=34434839
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE602004031435T Expired - Lifetime DE602004031435D1 (de) | 2003-09-11 | 2004-08-24 | Cycloalkyl-heterozyklen zur behandlung des hepatitis-c-virus |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US7112601B2 (cg-RX-API-DMAC10.html) |
| EP (1) | EP1663105B1 (cg-RX-API-DMAC10.html) |
| JP (1) | JP4897484B2 (cg-RX-API-DMAC10.html) |
| AT (1) | ATE498398T1 (cg-RX-API-DMAC10.html) |
| DE (1) | DE602004031435D1 (cg-RX-API-DMAC10.html) |
| ES (1) | ES2358904T3 (cg-RX-API-DMAC10.html) |
| WO (1) | WO2005034850A2 (cg-RX-API-DMAC10.html) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AT502258B1 (de) * | 2005-07-22 | 2007-09-15 | Univ Wien | Cox-i-inhibitorverbindungen |
| US20070032488A1 (en) * | 2005-08-05 | 2007-02-08 | Genelabs Technologies, Inc. | 6-Membered aryl and heteroaryl derivatives for treating viruses |
| WO2008019477A1 (en) * | 2006-08-17 | 2008-02-21 | Boehringer Ingelheim International Gmbh | Viral polymerase inhibitors |
| WO2008106166A2 (en) * | 2007-02-28 | 2008-09-04 | Conatus Pharmaceuticals, Inc. | Methods for the treatment of liver diseases using specified matrix metalloproteinase (mmp) inhibitors |
| WO2008106167A1 (en) * | 2007-02-28 | 2008-09-04 | Conatus Pharmaceuticals, Inc. | Combination therapy comprising matrix metalloproteinase inhibitors and caspase inhibitors for the treatment of liver diseases |
| MX2009011930A (es) | 2007-05-04 | 2009-11-18 | Vertex Pharma | Terapia de combinacion para el tratamiento de infeccion de virus de hepatitis c. |
| EP2193807A4 (en) | 2007-08-24 | 2012-09-12 | Univ Sapporo Medical | CYCLOSPORIN A-BINDING PROTEIN |
| EP2234977A4 (en) | 2007-12-19 | 2011-04-13 | Boehringer Ingelheim Int | VIRAL POLYMERASE INHIBITORS |
| UY32099A (es) | 2008-09-11 | 2010-04-30 | Enanta Pharm Inc | Inhibidores macrocíclicos de serina proteasas de hepatitis c |
| KR20110116136A (ko) | 2009-01-07 | 2011-10-25 | 싸이넥시스, 인크. | Hcv 및 hiv 감염의 치료에 사용하기 위한 사이클로스포린 유도체 |
| KR20140003521A (ko) | 2010-12-30 | 2014-01-09 | 이난타 파마슈티칼스, 인코포레이티드 | 페난트리딘 매크로사이클릭 c형 간염 세린 프로테아제 억제제 |
| CN103534256B (zh) | 2010-12-30 | 2016-08-10 | 益安药业 | 大环丙型肝炎丝氨酸蛋白酶抑制剂 |
| US10201584B1 (en) | 2011-05-17 | 2019-02-12 | Abbvie Inc. | Compositions and methods for treating HCV |
| WO2015103490A1 (en) | 2014-01-03 | 2015-07-09 | Abbvie, Inc. | Solid antiviral dosage forms |
| WO2019169193A1 (en) | 2018-03-01 | 2019-09-06 | Annapurna Bio Inc. | Compounds and compositions for treating conditions associated with apj receptor activity |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BR9611047A (pt) * | 1995-10-17 | 2000-03-08 | Searle & Co | Processo de deteção de ciclo oxigenase-2 |
| CA2338490A1 (en) | 1998-07-27 | 2000-02-10 | Sergio Altamura | Diketoacid-derivatives as inhibitors of polymerases |
| IL141456A0 (en) | 1998-08-21 | 2002-03-10 | Viropharma Inc | Rhodanine derivatives and pharmaceutical compositions containing the same |
| WO2000013708A1 (en) | 1998-09-04 | 2000-03-16 | Viropharma Incorporated | Methods for treating or preventing viral infections and associated diseases |
| BR9913935A (pt) | 1998-09-25 | 2001-06-19 | Viropharma Inc | Métodos de tratamento e prevenção de infecção causada por pelo menos um vìrus da famìlia dos flaviviridae e doença associada com a dita infecção em um hospedeiro vivo |
| AU1324300A (en) * | 1998-10-26 | 2000-05-15 | Vertex Pharmaceuticals Incorporated | Pentacyclic compounds useful as inhibitors of hepatitis c virus ns3 helicase |
| CA2389745C (en) | 1999-11-04 | 2010-03-23 | Shire Biochem Inc. | Method for the treatment or prevention of flaviviridae viral infection using nucleoside analogues |
| CZ20013424A3 (cs) | 1999-12-27 | 2002-02-13 | Japan Tobacco Inc. | Sloučeniny s fúzovanými kruhy a jejich pouľití jako léčiva |
| US6770666B2 (en) | 1999-12-27 | 2004-08-03 | Japan Tobacco Inc. | Fused-ring compounds and use thereof as drugs |
| US6448281B1 (en) | 2000-07-06 | 2002-09-10 | Boehringer Ingelheim (Canada) Ltd. | Viral polymerase inhibitors |
| EP1256628A3 (en) | 2001-05-10 | 2003-03-19 | Agouron Pharmaceuticals, Inc. | Hepatitis c virus (hcv) ns5b rna polymerase and mutants thereof |
| EP2363396A1 (en) | 2001-06-11 | 2011-09-07 | Virochem Pharma Inc. | Thiophene derivatives as antiviral agents for flavivirus infection |
| AR035543A1 (es) * | 2001-06-26 | 2004-06-16 | Japan Tobacco Inc | Agente terapeutico para la hepatitis c que comprende un compuesto de anillo condensado, compuesto de anillo condensado, composicion farmaceutica que lo comprende, compuestos de benzimidazol, tiazol y bifenilo utiles como intermediarios para producir dichos compuestos, uso del compuesto de anillo con |
| CA2448737C (en) | 2001-07-20 | 2010-06-01 | Boehringer Ingelheim (Canada) Ltd. | Viral polymerase inhibitors |
| EP2335700A1 (en) | 2001-07-25 | 2011-06-22 | Boehringer Ingelheim (Canada) Ltd. | Hepatitis C virus polymerase inhibitors with a heterobicylic structure |
| US20030134853A1 (en) * | 2001-09-26 | 2003-07-17 | Priestley Eldon Scott | Compounds useful for treating hepatitis C virus |
-
2004
- 2004-08-19 US US10/922,096 patent/US7112601B2/en not_active Expired - Lifetime
- 2004-08-24 ES ES04782095T patent/ES2358904T3/es not_active Expired - Lifetime
- 2004-08-24 JP JP2006526121A patent/JP4897484B2/ja not_active Expired - Fee Related
- 2004-08-24 WO PCT/US2004/027533 patent/WO2005034850A2/en not_active Ceased
- 2004-08-24 DE DE602004031435T patent/DE602004031435D1/de not_active Expired - Lifetime
- 2004-08-24 AT AT04782095T patent/ATE498398T1/de not_active IP Right Cessation
- 2004-08-24 EP EP04782095A patent/EP1663105B1/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| US7112601B2 (en) | 2006-09-26 |
| ATE498398T1 (de) | 2011-03-15 |
| JP4897484B2 (ja) | 2012-03-14 |
| WO2005034850A2 (en) | 2005-04-21 |
| ES2358904T3 (es) | 2011-05-16 |
| WO2005034850A3 (en) | 2006-03-16 |
| US20050075376A1 (en) | 2005-04-07 |
| EP1663105B1 (en) | 2011-02-16 |
| EP1663105A4 (en) | 2009-04-15 |
| EP1663105A2 (en) | 2006-06-07 |
| JP2007505114A (ja) | 2007-03-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EA200700338A1 (ru) | Ингибиторы рнк-зависимой рнк-полимеразы вируса гепатита с и композиции и способы лечения с их использованием | |
| ATE522532T1 (de) | Verbindungen zur behandlung von hepatitis c | |
| PL1987038T3 (pl) | Inhibitory HCV NS5B | |
| ATE469155T1 (de) | Cyclopropyl-fusionierte indolbenzazepin-hcv-ns5b- hemmer | |
| EA200802346A1 (ru) | Циклопропилконденсированные индолобензазепиновые ингибиторы белка ns5b вируса гепатита с | |
| CO5630024A2 (es) | Compuestos inhibidores de la hepatitis c | |
| ATE551343T1 (de) | Tetracyclische verbindungen zur behandlung von hepatitis c | |
| TW200518746A (en) | Novel inhibitors of hepatitis C virus NS3/NS4A serine protease | |
| ATE494291T1 (de) | Verbindungen zur behandlung von hepatitis c | |
| WO2004002940A8 (en) | Inhibitors of hcv ns5b polymerase | |
| EA200900298A1 (ru) | Ингибиторы вируса гепатита с | |
| TW200745120A (en) | Indolobenzazepine HCV NS5B inhibitors | |
| EA200800371A1 (ru) | Ингибиторы ns3 протеазы вгс | |
| MY164469A (en) | Hcv ns3 protease inhibitors | |
| JO2318B1 (en) | Nucleoside derivatives used as DNA-based viral RNA inhibitors | |
| ATE498398T1 (de) | Cycloalkyl-heterozyklen zur behandlung des hepatitis-c-virus | |
| ATE505473T1 (de) | Cyclopropylkondensierte indolobenzazepinderivate zur behandlung von hepatitis c | |
| MX2012008443A (es) | Nucleosidos antiviricos. | |
| DK2209789T3 (da) | Cyclopropyl-kondenserede indolobenzazepin HCV NS5B-hæmmere | |
| ATE432922T1 (de) | Substituierte 5-carboxyamidpyrazoles und ä1,2, 4ütriazole als viruzide | |
| MX2010001416A (es) | Compuesto para el tratamiento de la hepatitis c. | |
| NO20062146L (no) | Nukleosidforbindelser for behandling av virusinfeksjoner | |
| UA90909C2 (en) | Hcv ns3 protease inhibitors | |
| ATE491706T1 (de) | Heterocyclische antivirale verbindungen |